`
`SERIAL NUMBER: 79232007
`
`FILING DATE: 11/15/2017
`
`The table below presents the data as entered.
`
`Input Field
`
`Entered
`
`MARK SECTION
`IMAGE
`
`COLLECTIVE, CERTIFICATE OR GUARANTEE
`MARK
`
`MARK IN STANDARD CHARACTERS
`
`MARK IN COLOR
`
`THREE DIMENSIONAL MARK
`
`SOUND MARK
`
`THE WORDS CONTAINED IN THE MARK HAVE
`NO MEANING (AND THEREFORE CANNOT BE
`TRANSLATED)
`
`TM IMAGE: COLOR
`
`IMAGE FILE NAME
`
`TYPE (IMAGE TYPE)
`
`TEXTUAL ELEMENTS OF MARK
`
`HOLDER DETAILS
`CLIENT IDENTIFIER
`
`NOTIFICATION LANGUAGE
`
`NAME
`
`ADDRESS
`
`COUNTRY
`
`ENTITLEMENT ESTABLISHMENT
`
`LEGAL NATURE
`
`\\TICRS\EXPORT17\IMAGEOUT17\792\320\79232007\xml1\APP0002.JPG
`
`NO
`
`YES
`
`NO
`
`NO
`
`NO
`
`YES
`
`NO
`
`\\TICRS\EXPORT17\IMAGEOUT17\792\320\79232007\xml1\APP0002.JPG
`
`JPG
`
`AMIDI
`
`1083115
`
`ENGLISH
`
`miDiagnostics
`
`Kapeldreef 75
`
`B-3001 Leuven
`
`Belgium
`
`Benelux
`
`naamloze vennootschap (a joint stock company organized and existing under the laws
`of Belgium)
`
`LEGAL NATURE: PLACE INCORPORATED
`
`Not provided
`
`CORRESPONDENCE INDICATOR
`
`YES
`
`LIMITATION DETAILS
`DESIGNATED CONTRACTING PARTY CODE
`
`United States of America
`
`GOODS AND SERVICES LIMITED TO
`
`05
`
`GOODS AND SERVICES LIMITED TO
`
`Pharmaceutical preparations, namely diagnostic reagents for medical and veterinary
`use, for medical in-vitro analysis and diagnosis in humans and animals, integrated in
`an electronic device, consisting of one or more chips.
`
`GOODS AND SERVICES LIMITED TO
`
`09
`
`
`
`
`GOODS AND SERVICES LIMITED TO
`
`Software, including mobile applications, for performing an in-vitro analysis and
`medical diagnosis in humans and animals, the storing and recording of this data and
`for transmitting the information recorded; computer software platforms for enabling
`users to operate, cluster, view, track and to research data related to health; electronic
`chips, namely, semiconductor chips.
`
`GOODS AND SERVICES LIMITED TO
`
`10
`
`GOODS AND SERVICES LIMITED TO
`
`Analysis and diagnostic devices for medical use, integrated in an electronic device,
`consisting of one or more chips, namely, apparatus for performing a medical in-vitro
`analysis and medical diagnosis in humans and animals.
`
`GOODS AND SERVICES LIMITED TO
`
`42
`
`GOODS AND SERVICES LIMITED TO
`
`Providing scientific and technological services and research and design relating
`thereto, namely, research and design in the field of in-vitro diagnostics, medical
`research and scientific research information in the field of pharmaceuticals and
`clinical trials; medical research and scientific study and research, namely, scientific
`and biotechnological facilities and research for the health care with regard to the
`production, validation, development, storage, transport, and use in an electronic
`device, consisting of one or more chips, integrated pharmaceutical compositions and
`in-vitro analysis - and diagnostic tools; designing, installing, maintaining, developing
`and updating software, mobile software applications and computer software
`platforms; consultancy and providing information regarding the aforesaid services,
`including provided via electronic networks such as the internet.
`
`GOODS AND SERVICES LIMITED TO
`
`44
`
`GOODS AND SERVICES LIMITED TO
`
`BASIC GOODS AND SERVICES
`VERSION OF NICE CLASSIFICATION USED
`
`NICE CLASSIFICATION
`
`GOODS AND SERVICES
`
`Medical services and services in the field of healthcare, namely, healthcare and
`providing healthcare information.
`
`11
`
`05
`
`Pharmaceutical preparations for medical in-vitro analysis and diagnosis in humans
`and animals, integrated in an electronic device, consisting of one or more chips.
`
`NICE CLASSIFICATION
`
`09
`
`GOODS AND SERVICES
`
`NICE CLASSIFICATION
`
`GOODS AND SERVICES
`
`Software, including mobile applications, for performing an in-vitro analysis and
`medical diagnosis in humans and animals, the storing and recording of this data and
`for transmitting the information recorded; computer software platforms; data carriers;
`electronic chips.
`
`10
`
`Analysis and diagnostic devices for medical use, integrated in an electronic device,
`consisting of one or more chips.
`
`NICE CLASSIFICATION
`
`42
`
`GOODS AND SERVICES
`
`NICE CLASSIFICATION
`
`GOODS AND SERVICES
`
`PARIS PRIORITY DETAILS
`
`Providing scientific and technological services and research and design relating
`thereto; clinical trials; providing scientific and biotechnological facilities and
`research for the health care with regard to the production, validation, development,
`storage, transport, and use in an electronic device, consisting of one or more chips,
`integrated pharmaceutical compositions and in-vitro analysis - and diagnostic tools;
`designing, installing, maintaining, developing and updating software, (mobile)
`applications and computer software platforms; consultancy and information regarding
`the aforesaid services, including provided via electronic networks such as the
`internet.
`
`44
`
`Medical services and services in the field of healthcare.
`
`
`
`PARIS PRIORITY CODE:
`
`PARIS PRIORITY APPLICATION NUMBER
`
`PARIS PRIORITY APPLICATION DATE
`
`BASE REGISTRATION DETAILS
`BASE REGISTRATION NUMBER
`
`BASE REGISTRATION DATE
`
`BASE APPLICATION NUMBER
`
`BASE APPLICATION DATE
`
`REPRESENTATIVE DETAILS
`CLIENT IDENTIFIER
`
`NAME
`
`ADDRESS
`
`COUNTRY
`
`Benelux
`
`1358231
`
`07/26/2017
`
`1018862
`
`10/26/2017
`
`01358231
`
`07/26/2017
`
`1003093
`
`GEVERS
`
`Holidaystraat 5
`
`1831 Diegem
`
`Belgium
`
`INTENT TO USE GROUP
`CONTRACTING PARTY CODE
`
`DESIGNATIONS
`DESIGNATIONS UNDER THE PROTOCOL
`
`United States of America
`
`United States of America
`
`INTERNATIONAL REGISTRATION DETAILS
`INTERNATIONAL REGISTRATION NUMBER
`1401538
`
`INTERNATIONAL REGISTRATION DATE OF
`MARK
`
`11/15/2017
`
`INTERNATIONAL REGISTRATION EXPIRY DATE 11/15/2027
`
`EFFECTIVE DATE OF MODIFICATION
`
`NOTIFICATION DATE
`
`DATE OF RECORDAL IN INTERNATIONAL
`REGISTER
`
`IB DOCUMENT ID
`
`OFFICE OF ORIGIN CODE
`
`OFFICE REFERENCE
`
`11/15/2017
`
`05/17/2018
`
`04/30/2018
`
`1111207101
`
`Benelux
`
`79232007
`
`TRANSACTION TYPE VALUES
`
`Initial Designation
`
`ORIGINAL LANGUAGE
`
`INSTRUMENT UNDER WHICH CONTRACTING
`PARTY IS DESIGNATED
`
`DURATION OF MARK (YEARS)
`
`ENGLISH
`
`Protocol
`
`10
`
`
`
`
`AIMII
`
`